MERCK APPLAUDS THIS YEAR'S BOURSE FERNAND-SEGUIN RECIPIENTS

MONTREAL, May 19 /CNW Telbec/ - As a proud sponsor for 16 years now of the Bourse Fernand-Seguin, one of Canada's most prestigious fellowships for scientific journalism, Merck would like to offer heartfelt congratulations to this year's recipients. The 2011 edition marked the 30th anniversary of the competition.

"The Bourse Fernand-Seguin is a major stepping stone for young science communicators in Québec, having helped launch several journalists' promising careers. Merck is proud to be associated with this fellowship and to encourage young communicators to continue to popularize scientific knowledge, so that more people have access to the information," says Christine Homsy, Director of Public Affairs at Merck Canada.

"The Association des communicateurs scientifiques du Québec would like to acknowledge Merck Canada's contribution to the Bourse Fernand-Seguin. Merck has been a key figure in the growth of this competition for more than 16 years," adds Mathieu-Robert Sauvé, President of the Association des communicateurs scientifiques du Québec.

Merck Canada is committed to supporting young people who share its enthusiasm for research and scientific progress through various projects, such as the Science Fairs, which it has been supporting for the last 20 years, and the Bourse Fernand-Seguin. The company firmly believes in its commitment to the community. Merck's contribution to the Bourse Fernand-Seguin is a natural extension of its efforts to raise public awareness about science.

About Merck

Today's Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, consumer and animal health products. In Canada, Merck markets over 530 pharmaceutical, consumer and animal health products and is a leader in a broad range of areas such as cardiology, immunology, infectious diseases, respiratory, vaccines, women's health and sun care, and is focused on expanding offerings in other areas, including virology, oncology and diabetes.

Merck is one of the top 25 R&D investors in Canada, with an investment of $95.4 million in 2009. Merck also has a large manufacturing facility in Québec dedicated to the annual production of some 35 million units including the Claritin® and Aerius® brands. Based in Montréal, Québec, Merck employs over 1,600 people across Canada. For more information about our operations in Canada, visit www.merck.ca.

SOURCE MERCK CANADA INC.

For further information:

Ani Armenian
514-428-3395

Organization Profile

MERCK CANADA INC.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890